Gene · 2115
Papers2,342
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,342
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition. | Cancer Cell | 2023 | 36525973 | PubTator, text mining | PubMed |
| Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization. | Circulation | 2023 | 36524479 | PubTator, text mining | PubMed |
| Targeting PEA3 transcription factors to mitigate small cell lung cancer progression. | Oncogene | 2023 | 36509998 | PubTator, text mining | PubMed |
| A novel colony-stimulating factor 1 (CSF1) translocation involving human endogenous retroviral element in a tenosynovial giant cell tumor. | Genes Chromosomes Cancer | 2023 | 36504457 | PubTator, text mining | PubMed |
| Structural variation and eQTL analysis in two experimental populations of chickens divergently selected for feather-pecking behavior. | Neurogenetics | 2023 | 36449109 | PubTator, text mining | PubMed |
| Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes. | Cancer Discov | 2023 | 36399432 | PubTator, text mining | PubMed |
| The microphthalmia-associated transcription factor is involved in gastrointestinal stromal tumor growth. | Cancer Gene Ther | 2023 | 36241703 | PubTator, text mining | PubMed |
| A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets. | Nat Biotechnol | 2023 | 36217030 | PubTator, text mining | PubMed |
| Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS Fusions. | Mol Cancer Res | 2023 | 36125519 | PubTator, text mining | PubMed |
| Knock-out of 5-lipoxygenase in overexpressing tumor cells-consequences on gene expression and cellular function. | Cancer Gene Ther | 2023 | 36114329 | PubTator, text mining | PubMed |
| Analysis of rare driving events in pediatric acute myeloid leukemia. | Haematologica | 2023 | 35899387 | PubTator, text mining | PubMed |
| Molecular testing of soft tissue tumors. | Diagn Cytopathol | 2023 | 35808975 | PubTator, text mining | PubMed |
Response prediction in patients with gastric and esophagogastric adenocarcinoma under neoadjuvant chemotherapy using targeted gene expression analysis and next-generation sequencing in pre-therapeutic biopsies. | J Cancer Res Clin Oncol | 2023 | 35246724 | PubTator, text mining | PubMed |
| Deciphering the distinct transcriptomic and gene regulatory map in adult macaque basal ganglia cells. | Gigascience | 2022 | 38091510 | PubTator, text mining | PubMed |
| Dissecting the effects of androgen deprivation therapy on cadherin switching in advanced prostate cancer: A molecular perspective. | Oncol Res | 2022 | 37305018 | PubTator, text mining | PubMed |
| GENOMICS OF PROSTATE CANCER: CLINICAL UTILITY AND CHALLENGES. | Acta Clin Croat | 2022 | 36938554 | PubTator, text mining | PubMed |
| Interstitial Cells of Cajal-Origin, Distribution and Relationship with Gastrointestinal Tumors. | Medicina (Kaunas) | 2022 | 36676686 | PubTator, text mining | PubMed |
| ERK phosphorylation disrupts the intramolecular interaction of capicua to promote cytoplasmic translocation of capicua and tumor growth. | Front Mol Biosci | 2022 | 36619173 | PubTator, text mining | PubMed |
| Systematic Analysis of Cellular Signaling Pathways and Therapeutic Targets for SLC45A3:ERG Fusion-Positive Prostate Cancer. | J Pers Med | 2022 | 36579559 | PubTator, text mining | PubMed |
| Exploring biomarkers for prognosis and neoadjuvant chemosensitivity in rectal cancer: Multi-omics and ctDNA sequencing collaboration. | Front Immunol | 2022 | 36569844 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2115/papers?page=16